270 related articles for article (PubMed ID: 28770988)
1. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
Fiers WD; Craighead M; Singh I
ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres.
Parmar A; Iyer A; Lloyd DG; Vincent CS; Prior SH; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2017 Jul; 53(55):7788-7791. PubMed ID: 28650495
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine.
Jin K; Po KHL; Kong WY; Lo CH; Lo CW; Lam HY; Sirinimal A; Reuven JA; Chen S; Li X
Bioorg Med Chem; 2018 Mar; 26(5):1062-1068. PubMed ID: 29398444
[TBL] [Abstract][Full Text] [Related]
4. Rational Design and Synthesis of Modified Teixobactin Analogues: In Vitro Antibacterial Activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa.
Ng V; Kuehne SA; Chan WC
Chemistry; 2018 Jun; 24(36):9136-9147. PubMed ID: 29741277
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel teixobactin analogues.
Schumacher CE; Harris PWR; Ding XB; Krause B; Wright TH; Cook GM; Furkert DP; Brimble MA
Org Biomol Chem; 2017 Oct; 15(41):8755-8760. PubMed ID: 28993827
[TBL] [Abstract][Full Text] [Related]
6. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
[TBL] [Abstract][Full Text] [Related]
7. Teixobactin, the first of a new class of antibiotics discovered by iChip technology?
Piddock LJ
J Antimicrob Chemother; 2015 Oct; 70(10):2679-80. PubMed ID: 26089440
[TBL] [Abstract][Full Text] [Related]
8. Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo.
Parmar A; Lakshminarayanan R; Iyer A; Mayandi V; Leng Goh ET; Lloyd DG; Chalasani MLS; Verma NK; Prior SH; Beuerman RW; Madder A; Taylor EJ; Singh I
J Med Chem; 2018 Mar; 61(5):2009-2017. PubMed ID: 29363971
[TBL] [Abstract][Full Text] [Related]
9. Chemistry and Biology of Teixobactin.
Guo C; Mandalapu D; Ji X; Gao J; Zhang Q
Chemistry; 2018 Apr; 24(21):5406-5422. PubMed ID: 28991382
[TBL] [Abstract][Full Text] [Related]
10. Defining the molecular structure of teixobactin analogues and understanding their role in antibacterial activities.
Parmar A; Prior SH; Iyer A; Vincent CS; Van Lysebetten D; Breukink E; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2017 Feb; 53(12):2016-2019. PubMed ID: 28124045
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation.
Jin K; Po KHL; Wang S; Reuven JA; Wai CN; Lau HT; Chan TH; Chen S; Li X
Bioorg Med Chem; 2017 Sep; 25(18):4990-4995. PubMed ID: 28495382
[TBL] [Abstract][Full Text] [Related]
12. Efficient total syntheses and biological activities of two teixobactin analogues.
Parmar A; Iyer A; Vincent CS; Van Lysebetten D; Prior SH; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2016 Apr; 52(36):6060-3. PubMed ID: 26984316
[TBL] [Abstract][Full Text] [Related]
13. Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance.
Qi YK; Tang X; Wei NN; Pang CJ; Du SS; Wang K
J Pept Sci; 2022 Nov; 28(11):e3428. PubMed ID: 35610021
[TBL] [Abstract][Full Text] [Related]
14. Teixobactins: a new class of 21st century antibiotics to combat multidrug-resistant bacterial pathogens.
Iyer A; Madder A; Singh I
Future Microbiol; 2019 Apr; 14():457-460. PubMed ID: 31033354
[No Abstract] [Full Text] [Related]
15. Synthesis and structure-activity relationships of teixobactin.
Karas JA; Chen F; Schneider-Futschik EK; Kang Z; Hussein M; Swarbrick J; Hoyer D; Giltrap AM; Payne RJ; Li J; Velkov T
Ann N Y Acad Sci; 2020 Jan; 1459(1):86-105. PubMed ID: 31792983
[TBL] [Abstract][Full Text] [Related]
16. Gram-scale total synthesis of teixobactin promoting binding mode study and discovery of more potent antibiotics.
Zong Y; Fang F; Meyer KJ; Wang L; Ni Z; Gao H; Lewis K; Zhang J; Rao Y
Nat Commun; 2019 Jul; 10(1):3268. PubMed ID: 31332172
[TBL] [Abstract][Full Text] [Related]
17. Teixobactin kills bacteria by a two-pronged attack on the cell envelope.
Shukla R; Lavore F; Maity S; Derks MGN; Jones CR; Vermeulen BJA; Melcrová A; Morris MA; Becker LM; Wang X; Kumar R; Medeiros-Silva J; van Beekveld RAM; Bonvin AMJJ; Lorent JH; Lelli M; Nowick JS; MacGillavry HD; Peoples AJ; Spoering AL; Ling LL; Hughes DE; Roos WH; Breukink E; Lewis K; Weingarth M
Nature; 2022 Aug; 608(7922):390-396. PubMed ID: 35922513
[TBL] [Abstract][Full Text] [Related]
18. Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP).
Abdel Monaim SAH; Ramchuran EJ; El-Faham A; Albericio F; de la Torre BG
J Med Chem; 2017 Sep; 60(17):7476-7482. PubMed ID: 28795806
[TBL] [Abstract][Full Text] [Related]
19. Multiple attack on bacteria by the new antibiotic teixobactin.
von Nussbaum F; Süssmuth RD
Angew Chem Int Ed Engl; 2015 Jun; 54(23):6684-6. PubMed ID: 25968231
[No Abstract] [Full Text] [Related]
20. Simplified teixobactin analogues to target superbugs.
Singh I
Future Med Chem; 2018 Jan; 10(2):133-134. PubMed ID: 29241362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]